AstraZeneca to seek US approval of COVID vaccine in 2nd half
LONDON (AP) — AstraZeneca said Thursday that it intends to seek U.S. approval for its COVID-19 vaccine later this year, further delaying the application even as the company announced it had already delivered more than 1 billion doses to other countries.
from Google Alert - Business https://ift.tt/2V2C7yq
LONDON (AP) — AstraZeneca said Thursday that it intends to seek U.S. approval for its COVID-19 vaccine later this year, further delaying the application even as the company announced it had already delivered more than 1 billion doses to other countries. https://ift.tt/eA8V8J
from Google Alert - Business https://ift.tt/2V2C7yq
LONDON (AP) — AstraZeneca said Thursday that it intends to seek U.S. approval for its COVID-19 vaccine later this year, further delaying the application even as the company announced it had already delivered more than 1 billion doses to other countries. https://ift.tt/eA8V8J
Comments
Post a Comment